Sherman Leung

Dr. Sherman Leung is the Head of Research Operations at Wesley Research Institute - the official research partner for UnitingCare encompassing the four UnitingCare hospitals in Queensland as well as Lifeline, Blue Care, and Family and Disability Services. He is a PhD trained scientist, conducting his research training at The University of Queensland.

His research is published in highly regarded peer-reviewed journals, including recently in 'Diabetes', receiving the Cover Image, an 'In This Issue' feature, and shared across the Australian-wide 7 Network news. He has extensive experience in clinical trials, having worked at Microba Life Sciences, an ASX-listed biotechnology start-up, and Nucleus Network, Australia’s largest early phase clinical trial site having overseen the conduct of several high-profile COVID-19 projects including that of Nuvaxovid by Novavax that is now authorised for use by the TGA, EMEA & FDA across many jurisdictions worldwide.

At Wesley Research Institute, he is responsible for the Clinical Trials Centre, Biobank, Research Office and all research programs across the health and medical sciences. He contributes his time to numerous initiatives in the industry including being on the Editorial Board for 'Trials', being a former member of the Metro North Human Research Ethics Committee (HREC), and classrooms on clinical trials, informed consent and ethics to medical and postgraduate students at The University of Queensland.